ABSTRACT In vertebrates, the neural crest and placodes originate in the neural border, which is located between the neural plate and epidermal ectoderm. The neural crest and placodes give rise to a vast array of cell types. Formation of neural crest is a multi-step process, in which Wnt signals are used reiteratively, but it is currently not clear if a Wnt signal is required for neural border formation. Here, we have identified apolipoprotein C-I (apoc1) in a screen for genes regulated by Wnt/ Ctnnb1 signaling in late blastula stage Xenopus tropicalis embryos. We show that Xenopus laevis apoc1 encodes a small, secreted protein, and is induced by Wnt/Ctnnb1 signaling. Depletion of Apoc1 protein results in a neural border formation defect and loss of border fates, including neural crest cells. However, unlike another Wnt/Ctnnb1 target, gbx2.2, apoc1 is not required for patterning of the neural border. We further show that gbx2.2 and apoc1 are independently regulated by Wnt signaling. Our results thus suggest that Wnt regulates border formation and patterning by distinct genetic mechanisms.
Introduction
Neural crest cells constitute a transient cell population that is unique to vertebrate embryos. Together with the placodes, this multipotent and self-renewing cell population forms the glia and neurons of the peripheral nervous system. In addition, the neural crest contributes a vast array of other cell types to the developing embryo, such as blood vessels, melanocytes, and craniofacial cartilage and bones (Sauka-Spengler and Bronner-Fraser 2008) . Development of neural crest cells has been suggested to occur in five sequential steps: neural border induction, neural crest induction, neural crest specification, neural crest migration and neural crest differentiation (Pegoraro and Monsoro-Burq 2013) . In Xenpous, Wnt, Bmp, and Fgf signals begin patterning the ectoderm already during the blastula stage resulting in the formation of neural ectoderm, epidermal ectoderm, and the neural border (hereafter referred to as the border) from which both neural crest and placodal cells originate (Pegoraro and Monsoro-Burq 2013) .
Conflicting reports exist on the involvement of Wnt signals in border formation. While one study proposed that an initial Wnt signal is required to initiate Bmp-mediated border formation (Patthey et al., 2009) , another suggested that Wnt activity initially need to be repressed for border formation . Induced border cells are characterized by expression of border specifiers, e.g. members of the dlx, msx, pax and zic families, which stabilize the border fate (Patthey and Gunhaga 2011; Milet and Monsoro-Burq 2012) . At gastrula stages, regionalization of the border then allows induction of neural crest cells and placodal cells from the posterior and anterior border, respectively. Later, at neurula stages, the posterior border is further regionalized resulting in formation of neural crest from the medial border and posterior placodes from the lateral border. Wnt is required for posteriorizing the border, and gbx2.2 mediates this activity (Patthey et al., 2008; Li et al., 2009) . Induction of neural crest requires the combined action of the border specifiers and signals, including Wnt, Bmp, and Fgf, produced by surrounding tissues (Hong et al., 2008) . For example, pax3 and zic1 are capable of inducing neural crest in the ventral Xenopus embryo, but only if Wnt signaling is not blocked (Sato et al., 2005) . Neural crest induction results in the activation of neural crest specifiers, including snai2, foxd3, and sox9, which initiate epithelial-to-mesenchymal transition, neural crest cell migration and differentiation (Duband 2010; Milet and Monsoro-Burq 2012) . The timing of differentiation is correlated with the final fate/ destination of the specific cell type (Theveneau and Mayor 2012) . Members of the Wnt family are secreted glycoproteins, which can activate at least three intracellular signaling pathways. The most intensively studied pathway is the Wnt/Ctnnb1 pathway (formerly "canonical pathway") that regulates cellular processes by Ctnnb1-mediated transcriptional activation of downstream target genes. In Ctnnb1-depleted embryos, the neural plate is dramatically expanded and border fates suppressed, suggesting that ctnnb1 is required to inhibit neural induction and to promote the specification of border fates, possibly by regulating neural border 
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formation (Heeg-Truesdell and LaBonne 2006) . In addition, ectopic expression of ctnnb1 will posteriorize the anterior border (Li et al., 2009) . Thus, available data suggests that both Wnt ligands and Ctnnb1 transcriptional activity is instrumental for the developmental program that ultimately results in formation of neural crest cells.
In adult mice and humans, members of the apoliporotein family bind lipids to form lipoprotein particles. They function in lipid transport, but also as coenzymes. In addition, they can interact with lipoprotein receptors (Bolanos-Garcia and Miguel 2003) . Mouse and human apolipoprotein c1 (apoc1) may influence memory functions and contribute to the pathogenesis of Alzheimer's disease (Berbee et al., 2011) . In adult Xenopus laevis, apoc1 is predominantly expressed in the liver, but also in the stomach, gonads, intestines, and ovarian follicles during late oogenesis (Gohin et al., 2010) . However, a role for apoc1 during early vertebrate development has not been reported.
In a screen for Wnt/Ctnnb1-regulated genes in late blastula stage Xenopus tropicalis embryos, we identified a strongly regulated transcript, which encodes for apoc1. Using Xenopus laevis, we demonstrate that Wnt can activate apoc1 in both embryos and ecodermal explants. Furthermore, we show that apoc1 is required for development of border cells fates, including neural crest cells. Previously, gbx2.2 has been suggested to be the earliest Wnt/ Ctnnb1 target in neural crest formation (Li et al., 2009) . However, we show that gbx2.2 and apoc1 are independently regulated by Wnt and mediate separate activities. Our data suggest a model where apoc1 functions as a critical mediator of Wnt in border formation. However, apoc1 is not required for patterning of the border along the anteroposterior axis, a function performed rather by gbx2.2.
Results

Identification, characterization, and regulation of Xenopus apoc1
To better understand the role of Wnt/Ctnnb1 signaling in early development, e.g. in ectoderm patterning, we attempted to discover novel Wnt target genes by comparing the transcriptional profiles of late blastula (Nieuwkoop and Faber stage 9.5) Xenopus tropicalis embryos where Wnt/Ctnnb1 signaling is normal (uninjected embryos), decreased (embryos injected with axin1 mRNA) or increased (embryos injected with a constitutively active form of ctnnb1 mRNA; Fig. 1 A-C) . We identified an unannotated genomic region, scaffold_701:348314-352838 (JGI v4.1), predicted by TopHat/Cufflinks to encode a transcript that exhibits strong Wnt/Ctnnb1 regulation (uninjected: 9,44 Fragments Per Kilobase of transcript per Million fragments mapped (FPKM), axin1 injected 0,70 FPKM, ctnnb1 injected: 138,33 FPKM; Fig. 1A) . Inspection of the genomic region in the UCSC genome browser revealed numerous unspliced ESTs with 3 or 4 exons. A nucleotide BLAST analysis of the genomic region identified a RefSeq predicted mRNA (XM_002941032.1) with four exons, encoding an 85 amino acid protein (XP_002941078) containing an Apolipoprotein C-I conserved domain (pfam04691). Further analysis using BLASTP of the predicted Xenopus tropicalis protein identified the 89 amino acid Xenopus laevis Apolipoprotein C-I (Apoc1) protein (ADD51575.1) as the closest ortholog with 66/89 (74%) identical and 78/89 (87%) positive amino acids.
We used SignalP 4.1 to analyze the Xenopus laevis and tropicalis Apoc1 protein sequences for possible signal peptides (www.cbs. dtu.dk/services/SignalP). Both proteins contain a putative signal peptide, but no transmembrane domain, suggesting that they are secreted proteins. To test whether Apoc1 is secreted in Xenopus embryos, we injected C-terminally flag-tagged Xenopus laevis apoc1 or flag-tagged ctnnb1 mRNA at the 4-cell stage and collected the blastocoel fluid from stage 10 (early gastrula) embryos (Fig. 1D) . As predicted, Apoc1, but not Ctnnb1, was detected by Western blot analysis in the blastocoel fluid (Fig. 1E) .
Our screen established that apoc1 is Wnt/Ctnnb1 regulated in Xenopus tropicalis. To further test whether Wnt/Ctnnb1 signaling regulates apoc1 expression also in Xenopus laevis, we injected wnt3a, the BMP antagonist chordin/wnt3a mRNA into embryos and performed RT-PCR on dissected animal caps at stage 10. As predicted, both apoc1 and the well-established direct Wnt/Ctnnb1 target gene nodal3.2 were strongly upregulated (Fig. 1F) . We then asked if apoc1 is a direct target of Wnt/Ctnnb1 signaling in Xenopus laevis (Fig. 1G) . Previous studies have shown that both gbx2.2 and pax3 but not snail2 were direct targets of Wnt/Ctnnb1 signaling (de Croze et al., 2011; Li et al., 2009) , and our result in Fig 1G confirmed this. Strong ectopic expression of apoc1, gbx2.2 and pax3 were observed overlapping area where GR-Ctnnb1 was expressed even in the cycloheximide treated embryos. These data suggested that apoc1 is a direct target of Wnt/Ctnnb1 signaling.
Apoc1 is expressed at the neural plate border and in neural crest cells We next determined the temporal expression profile of apoc1 in Xenopus laevis embryos ( Fig. 2A) . While we could not detect any expression by RT-PCR analysis in 4-cell stage embryos, we found low levels of apoc1 in early gastrula (stage 10) embryos, consistent with our screen data, detecting low-level expression in late blastula (stage 9.5) Xenopus tropicalis embryos. The expression level increased dramatically by late gastrula (stage 12) and remained high during embryonic development (until stage 32; tadpole stage).
To determine the spatiotemporal distribution of apoc1 mRNAs, we performed whole mount in situ hybridization (WISH) on stages 11 to 30 (gastrula to tadpole) Xenopus laevis embryos ( Fig. 2 B-P). Robust Apoc1 expression was first detected by WISH at stage 10.5 in the dorsal animal region (data not shown). At stage 11, the area of expression stretched towards the dorso-anterior and dorso-lateral part of the embryo along the gastrulation movement ( Fig. 2 B,C) . At the neurula stage, apoc1 was highly expressed in parts of the preplacodal ectoderm, cranial neural crest cells, posterior neural plate border cells, the neural folds, and migrating neural crest cells (Fig. 2D-O) . In stage 30 embryos, expression remained high in the dorsal fin, which consists of neural crest derived cell types (Fig. 2P) . At this stage, apoc1 expression was also detected in cranial placodes, including the lens placode, and in the mandibular neural crest. In summary, the apoc1 expression pattern suggests a function for apoc1 in neural crest and cranial placode development.
Apoc1 is required for neural crest development
To determine whether apoc1 is required for neural crest development in vivo, we designed a translation blocking morpholino antisense oligo (tbMO) to prevent Apoc1 protein synthesis (Fig. 3A) . As the genome sequence for Xenopus laevis was not yet available, an analysis of more than 50 expressed sequence tags (ESTs) was performed to identify a tbMO binding site that was conserved in the 5 prime untranslated sequence (5'UTR) of all ESTs. To determine the efficiency of the Apoc1 tbMO, we co-injected it (or control MO) with +/-5'UTR flag-tagged apoc1 mRNA ( Fig. 3A) and analyzed the Apoc1 protein expression levels in gastrula stage embryos. The Apoc1 tbMO efficiently blocked translation of apoc1 mRNA only when it contained the tbMO target sequence ( designed a splice blocking MO (spMO) against apoc1 and assayed its efficiency by RT-PCR (Fig. 3C ). Expression of apoc1 mRNA was detected in stage 10 embryos that had been injected with control MO, but not in embryos injected with the spMO suggesting that it efficiently blocked the splicing of apoc1 pre-mRNA (Fig. 3C ).
We next analyzed the consequences of Apoc1 depletion in Xenopus embryos by co-injecting the Apoc1 tbMO with lacZ mRNA, encoding for beta-galactosidase, as a lineage tracer (Fig. 3D ). The tbMO was first targeted to the presumptive cranial neural crest region from which craniofacial cartilage and bone forms (Fig. 3F , G). We apoc1 is required for neural border formation 419 allowed the embryos to develop until they reached the tadpole stage. Apoc1 depleted embryos exhibited clear head developmental defects including smaller or missing eyes (76.1%, n=134; supplementary material Table S1 ). Next, we targeted the tbMO to the presumptive trunk neural crest region from which cells of the dorsal fin derives (Fig. 3 H,I ). Clear defects in dorsal fin formation were observed (55.3%, n=38; Fig. 3 H,I ; supplementary material Table S1 ), with the heads unperturbed. Control MO injected embryos exhibited no developmental defects (Fig. 3E) . To further strengthen these observations, we injected the spMO into the presumptive cranial or trunk neural crest regions, and, as expected, we observed head developmental (56.4%, n = 55) or dorsal fin formation defects (45.2%, n = 31) respectively ( Fig. S1 ; supplementary material Table  S1 ). As both the tbMO and spMO efficiently depleted the Apoc1 protein levels and resulted in identical phenotypes, we mainly used the tbMO in subsequent experiments.
Given that apoc1 expression was detected prior to neural crest induction, we next wanted to determine whether apoc1 is essential for neural crest emergence. Thus, we co-injected Apoc1 tbMO together with lacZ mRNA, and analyzed the expression of the neural crest markers c-myc, sox9, snai2 and twist1 by in situ hybridization (Fig. 4A) . Consistent with an early role for apoc1 in neural crest development, expression of these genes was missing or significantly downregulated on the injected side of early neurula stage embryos (supplementary material Table S2 ). Furthermore, depletion of apoc1 mRNA with the spMO also resulted in reduced snail2, sox9, twist1, pax3 and zic1 expression ( Fig. S2 ; supplementary material Table S2 ). The reduction/loss of neural crest markers could be rescued by injecting tbMO resistant apoc1 mRNA ( Fig. 4B upper panel; supplementary material Table S2 ), but not by injecting apoc1 mutant mRNA lacking signal sequence ( Fig. 4B lower  panel; Fig. S3 ; supplementary material Table S2 ). These results demonstrate that the morpholino phenotype is indeed caused by a specific depletion of Apoc1 protein, and secretion is required for its function.
Bellmeyer and colleagues have shown that inhibition of Wnt signaling results in lost c-myc expression already in gastrula stage embryos, and that c-myc is required for expression of definitive neural crest markers (Bellmeyer et al., 2003) . Apoc1 depletion resulted in reduced or completely lost c-myc expression, placing apoc1 downstream of wnt, but upstream of c-myc. Furthermore, c-myc has been demonstrated to regulate id3 (Light et al., 2005) . We therefore examined id3, which controls the maintenance of neural crest stem cell behavior, in Apoc1-depleted embryos. Indeed, id3 expression was downregulated or missing ( Fig. 4A ; supplementary material Table S2 ). Neural crest cells originate from the border between the neural and epidermal ectoderm. The expression of neural crest markers is preceded by expression of border specifiers, such as msx1, pax3 and zic1 (Fig. 4C) . C-myc depleted embryos also exhibit border defects, suggesting that c-myc also can be considered a border specfier. More specifically, in C-myc morphants, zic1 and the neural precursor marker sox2 are both expanded laterally. In Apoc1 depleted embryos, zic1 and sox2 are both expanded laterally ( Fig. 4C ; supplementary material Table S2 ), and the medial boundary of xk81a1 (keratin), which is expressed in epider-mal ectoderm, is shifted laterally ( Fig. 4C ; supplementary material Table S2 ). Furthermore, expression of the border marker msx1, was depleted in Apoc1-depleted embryos ( Fig. 4C ; supplementary material Table S2 ). Interestingly, Msx1 morphants also exhibit an expanded sox2 expression domain, and a lateral shift of the medial xk81a1 expression boundary (Monsoro-Burq et al., 2005) .
Pax3 is a border specifier and required for neural crest induction. Furthermore, it is sufficient for neural crest induction in vivo and in animal caps when ectopically expressed together with zic1 (Sato et al., 2005) . It has been shown that pax3 is an immediate-early target of Wnt signaling in neural border induction (de Croze et al., 2011) . We then examined pax3 expression in Apoc1 morphants and observed a dramatic downregulation in pax3 expression in the neural folds ( Fig. 4C ; supplementary material Table S2 ). This result indicates that Wnt signaling directly induces initial expression of pax3, and apoc1 maintains the expression of pax3 in neural border. Together these results demonstrate that apoc1 is required for border formation.
Apoc1 together with BMP antagonists can induce neural crest markers in a neural crest induction assay
We have demonstrated that apoc1 is activated by Wnt/Ctnnb1 signaling both in vivo and in animal caps. The combined activity of Wnt ligands and BMP antagonists in animal caps results in a potent induction of neural crest cells (Saint-Jeannet et al., 1997) . Thus, we asked if apoc1 could also induce neural crest markers with BMP antagonist in the animal cap neural crest induction assay. We injected embryos at the 4-8 cell stage with apoc1, the BMP antagonist chordin (chrd), chrd/wnt3a, and chrd/apoc1, dissected animal caps at stage 9 and cultured them until control embryos reached a late neurula stage (stages 19; Fig. 5A ). As expected, RT-PCR analysis of the late neurula stage samples demonstrated that chrd alone can activate zic1 expression, but does not result in neural crest induction. However, chrd in combination with wnt3a robustly induced the neural crest specifiers foxd3, snai2, sox9, snai1, and the border specifier pax3. Expression of apoc1 alone did not activate any of the genes assayed, but in combination with chrd, apoc1 robustly induced the expression of all markers. This result suggested that apoc1 is a key mediator of Wnt/Ctnnb1 signaling in neural crest induction. To determine if apoc1 is also required for Wnt-mediated neural crest induction in animal caps, we injected a dominant negative form of bmpr1a and a constitutively active form of ctnnb1 with or without Apoc1 MO, dissected animal caps at stage 9, and performed RT-PCR at stage 16 (Fig. 5B) . Apoc1 MO coinjection strongly suppressed the NC markers foxd3, snai2 and sox9. Furthermore, the expression of these markers was restored by injecting morpholino resistant apoc1 mRNA (Fig. 5B) . Taken together, apoc1 is required for Wnt-mediated neural crest induction in animal caps. As previous study showed (Li et al., 2009 ), gbx2.2 was induced in the animal caps injected with dominant negative form of bmpr1a and a constitutively active form of ctnnb1, and its expression was not changed by injecting Apoc1 tbMO.
Chrd can be replaced both in vitro and in vivo with the chrdinduced gene zic1 to, in combination with e.g. pax3 or gbx2.2, induce neural crest markers (Sato et al., 2005; Li et al., 2009) . As apoc1 and chrd together could induce neural crest markers in vitro, we examined if apoc1 together with zic1 could induce ectopic neural crest markers in vivo (Fig. 5C) . Injection of zic1 alone in the ventral embryo could not induce sox9 or snai2, but apoc1 together with zic1 induced robust ectopic sox9 and snai2 ( Fig. 5C ; supplementary material Table S3 ). apoc1 and gbx2.2 are both required for neural crest induction and are independently regulated by Wnt/Ctnnb1 signaling Li et al., have suggested that gbx2.2 is the earliest target of Wnt/Ctnnb1 signaling in neural crest induction (Li et al., 2009) . To determine the epistatic relationship between endogenous apoc1 and gbx2.2, we analyzed apoc1 expression in Gbx2.2 MO injected embryos and gbx2.2 expression in Apoc1 MO injected embryos (Fig.  6A-D) . Interestingly, neither gene appeared regulated by the other Table S4 ). Thus, apoc1 and gbx2.2 are both required for neural crest development, but independently regulated. To determine whether both apoc1 and gbx2.2 are required for Wnt/Ctnnb1 mediated neural crest induction in vivo, GR-Ctnnb1 was targeted to the neural plate/neural border region and activated by DEX at an early gastrula stage. As expected, the snai2 and sox9 expression domains were both expanded anteriorly ( Fig.  6I, J ; supplementary material Table S4 ), and in some embryos, expression was even detected in the neural plate (Fig. 6I) . Strong ectopic expression of both apoc1 and gbx2.2 was observed overlapping the entire area where GR-Ctnnb1 was expressed ( Fig.  6K , L; supplementary material Table S4 ). In addition, msx1 and pax3 were also found to be ectopically expressed (Fig. 6 M,N ; supplementary material Table S4 ).
We then coinjected GR-Ctnnb1 and Apoc1 tbMO or Gbx2.2 MO. The anterior expansion of snail2 was rescued in both morphants (Fig. 6 O Table S4 ). Taken together, the expression of apoc1 and gbx2.2 are regulated independently by Wnt/Ctnnb1 signaling, but both are required for neural crest induction in vivo.
Apoc1 does not regulate regionalization of the border
Our findings show that apoc1 is a key mediator of Wnt/Ctnnb1 signaling in border formation, but Wnt/Ctnnb1 signaling has also been reported to posteriorize the border (Patthey et al., 2008; Li et al., 2009) . Therefore, to investigate whether apoc1 is sufficient for posteriorizing the neural border, apoc1 mRNA was targeted to the neural border. Unlike after expression of wnt or gbx2.2 in the anterior border (Li et al., 2009) , no anterior expansion of pax3 or snai2 was observed, and the preplacodal marker foxi4.1 was maintained (Fig. 7 A-C; supplementary material Table S5 ). Apoc1 is thus not sufficient to promote posteriorizaton of the anterior neural border.
In Gbx2.2 morphants, the posterior border is anteriorized. We therefore analyzed foxi4.1 also in Apoc1 morphants (Fig. 7 D-F) . Rather than a posterior expansion, we found that foxi4.1 was lost in the most posterior part of the preplacodal domain ( Fig. 7F ; supplementary material Table S5 ). This result shows that gbx2.2 and apoc1 have opposite effects on preplacodal development; gbx2.2 inhibits, but apoc1 is required for expression of preplacodal markers. Thus, these results argue that while apoc1 is required for mediating Wnt's border specification and neural crest induction activities, it is, unlike gbx2.2, not acting as a posteriorizing factor. 
(L), msx1 (M), and pax3 (N). Ectopic expression of gbx2.in GR-ctnnb1 injected embryos was not reduced by coinjecting 30 ng Apoc1 tbMO (P), but the anterior expansion of snaiwas rescued (O). Ectopic expression of apoc1 in GR-ctnnb1 injected embryos was not reduced by coinjecting 30 ng Gbx2.MO (R), but the anterior expansion of snaiwas rescued (Q). Blue arrowhead indicates ectopic expression.
To further support this claim, we turned to the animal cap assay and analyzed border and neural crest markers at stage 14 (early neurula stage; Fig. 7G ). As was shown in late neurula stage animal explants (Fig. 5) , apoc1 (or wnt) together with chrd can induce snai2 and pax3 (Fig. 7G) . The zic1 level was even in all chrd-injected animal explants, and as expected, coinjection of wnt and chrd reduced expression of the preplacodal marker six1 and the anterior neural and placodal marker otx2 (Fig. 7G) . These results confirm the posteriorizing effect of wnt expression. However, while coinjection of chrd and apoc1 induced neural crest markers, it failed to repress sox2, six1 and otx2 (Fig. 7G) . These three markers are all expressed in the anterior border or placodes. Our data thus suggests that apoc1 is required to mediate the border specification, but not the border regionalization, activity of Wnt/ Ctnnb1 signaling.
Discussion
We identified the apolipoprotein apoc1 in a screen for Wnt/ Ctnnb1-regulated genes in late blastula Xenopus tropicalis embryos. Using Xenopus laevis, we confirmed this finding and demonstrated that Apoc1-depleted tadpoles exhibited defects in the formation of neural crest-and placode-derived cell types. In vertebrates, both placodal and neural crest cells are generated from the border, albeit from distinct regions. While the anterior border produces placodal cells, the posterior border generates both neural crest (medial border) and placodal cells (lateral border). The emergence of neural crest and placodal cells are complex, multi-step processes (Meulemans and Bronner-Fraser 2004; Betancur et al., 2010) , which are initiated already in the late blastula/early gastrula stage embryo at which time cells of the border are induced (Patthey and Gunhaga 2011). Our study has revealed an absolute requirement for the Wnt/Ctnnb1 signaling target apoc1 in border formation, suggesting that a Wnt signal is required in blastula stage embryos to promote border formation.
Wnt/Ctnnb1 signals are used reiteratively during neural crest development. Wnts have been clearly demonstrated to regulate antero-posterior border patterning and neural crest induction (Saint-Jeannet et al., 1997; LaBonne and Bronner-Fraser 1998) . Previous studies have provided conflicting data on whether Wnt activity is required for, or actually inhibits, border formation. While one study suggested that Wnt activity needs to be repressed for border induction, and then activated for neural crest induction (Steventon and Mayor 2012), another proposed that Wnt is required to initiate a BMP-dependent neural border induction mechanism (Patthey et al., 2009 ). In addition, Wnt/Ctnnb1 has been shown to be required for inhibiting neural induction and promoting neural crest development (Heeg-Truesdell and LaBonne 2006). When Wnt activity was ablated using dominant negative lef1 or tcf3 constructs, or Ctnnb1 morpholinos, c-myc was repressed, the neural plate was expanded laterally and neural crest cells were not formed (Heeg-Truesdell and LaBonne 2006) . Taken together with the observation that c-myc is required for border formation (Bellmeyer et al., 2003) , and our findings in this study: that apoc1 functions upstream of c-myc in border formation and that apoc1 is a Wnt/Ctnnb1 target, argues for an early Wnt/Ctnnb1 requirement for ensuring the formation of a proper border domain. Consistent with the idea that at least the neural crest producing border cells originate from the lateral neural tube, we showed that activating Wnt signaling in the early neural plate using DEX-inducible GR-ctnnb1 results in strong ectopic expression of apoc1, gbx2.2, msx1 and pax3 in the neural plate. In fact, in some embryos, expression of snai2 was also detected in the neural domain, suggesting that a continuous Wnt/Ctnnb1 signal is sufficient to respecify some neural cells into neural crest-producing border cells.
Several studies have demonstrated that, at gastrula stages, Wnt/ Ctnnb1 is required for patterning the border into separate anterior and posterior domains. Secreted or intracellular Wnt antagonists, such as dkk1 or kctd15, are required for the border to acquire anterior character. Furthermore, the anterior border expresses posterior markers upon ectopic expression of wnt or ctnnb1 and produces neural crest cells rather than placodal cells. Gbx2.2 has been shown to be a direct target of Wnt/Ctnnb1 signaling and et al., 2012) , a mechanism that also patterns the central nervous system (Nordstrom et al., 2002) . In contrast, apoc1 expression in the anterior border does not repress the placodal marker foxi4.1, and conversely, foxi4.1 is not expanded posteriorly in Apoc1-depleted embryos. In fact, the posterior limit of the foxi4.1 domain is shifter anteriorly, which is consistent with the observed loss of placodal fates in tadpole morphants and a requirement for apoc1 in border formation.
As pax3 and msx1 is lost in Gbx2.2-depleted embryos, it had been suggested that gbx2.2 should be placed at the top of the hierarchy of genes controlling neural crest development (Li et al., 2009) . However, unlike Apoc1-depleted embryos, Gbx2.2 morphants were not reported to exhibit an expanded neural plate and neural border formation defects. In fact, the border was formed but the patterning perturbed resulting in loss of neural crest fates. Given the spatiotemporal expression pattern of apoc1, first appearing in the dorsal region at the onset of gastrulation followed by expression in the border, except the most anterior part, apoc1 is likely to be the immediate Wnt-regulated genes in border formation. This prompted us to examine the epistatic relationship between apoc1 and gbx2.2. We found that apoc1 and gbx2.2 are independently regulated by Wnt signaling, both in the early embryo and upon targeting expression of GR-ctnnb1 to the nervous system. Based on these observations, we propose a model in which Wnt regulates border formation and border patterning by two independent genetic programs. We suggest that apoc1 mediates Wnts border formation activity and gbx2.2 the anteroposterior patterning activity. Thus our study provides further insights into the genetic mechanism by which Wnt controls two distinct steps of the neural crest developmental program. Furthermore, apoc1 remains expressed after border formation, in the neural folds and migrating neural crest, suggesting that it may be required also for neural crest induction, migration or differentiation.
The cellular and molecular mechanisms by which apoc1 contributes to border formation remain to be elucidated. Apoc1 is a member of the apolipoprotein family that binds lipids to form lipoprotein such as chylomicrons, IDL, LDL, VLDL, and HDL. These lipoproteins transport lipids through the lymphatic and circulatory systems. In addition, apolipoproteins have been demonstrated to act as ligands for cell surface receptors (Li et al., 1988) . There are four members of the apoc subfamily of low molecular weight apolipoproteins. The human apoc1 gene is located in the apoe/c1/ c2 gene cluster on chromosome 19 (Jong et al., 1999) . Both apoc1 and apoe4 are known to be risk factors for Alzheimer's disease (AD), possibly by controlling the cellular cholesterol homeostasis in the brain (Leduc et al., 2010) , although a detailed mechanism has not been provided.
This study is one of the first to ascribe a function to apoc1 during embryonic development. The demonstration that apoc1 activity is required as early as during late blastula is interestingly since a circulatory system has yet to be established at such early stages of Xenopus development, possibly suggesting a novel molecular mechanism. In mice, both overexpression and knock out of apoc1 results in impaired memory functions (Berbee et al., 2011) , but no embryonic defects have been reported. This suggests that, in mouse, there might be either redundancies, a requirement for a different apolipoprotein family member, or a different mechanism for establishing the neural border.
Several studies have shown that apoe is a physiologically relevant ligand for low-density lipopotein receptors (LDLRs) and LDLR related proteins (LRPs) (Zaiou et al., 2000) . Apoc1 can also inhibit apoe-mediated b-VLVL binding to LRP (Weisgraber et al., 1990) suggesting the possibility of direct binding of apoc1 to LRPs. Therefore, we examined the possibility that apoc1 modulates Wnt signaling by using a reporter construct (TOP-flash assay; Fig. S4 ). Since we showed that secretion of Apoc1 protein was required for its function (Fig. 4B) , it might be possible that Apoc1 cooperates with extracellular Wnt components such as Wnt ligand or the Wnt antagonist Dkk1. We, therefore, examined TOP-FLASH reporter assays using lrp6, apoc1 together with either low amount of wnt3a or dkk1 in Xenopus animal caps (Fig. S4B) , however, we did not observe any activation or repression of Wnt activity when apoc1 was coexpressed (Fig. S4B ). These data suggested that the molecular mechanism by which apoc1 functions in early development is not by modulating wnt signaling. Further studies are required to fully understand the molecular function of apoc1 in Xenopus embryos.
Materials and Methods
Xenopus embryos and animal cap assays
Animal care and research protocols were in accordance with institutional guidelines, and approved by the Etiska Nämnden on animal use. Xenopus laevis eggs were obtained by injecting frogs with 700 units human chorionic gonadotropin (Pregnyl®, Merck Sharp & Dohme). The eggs were fertilized using a sperm suspension. The embryos were dejellied with 1% thioglycolic acid, and cultured in 0.2x Marc's Modified Ringer's solution (MMR) at 18-20ºC. Staging was according to Nieuwkoop and Faber (Nieuwkoop and Faber 1994) . Ectodermal explants (animal caps) were dissected at stage 9 in 0.2x MMR, and cultured in 0.4x MMR, 0.1% BSA until control embryos reached the desired stage. Xenopus tropicalis embryos were obtained by artificial insemination and cultured in 20% Steinberg's Solution (SS) at 23-25°C. Fertilized eggs were dejellied using 4% L-Cystein in 20% SS pH 8.0.
Microinjection and DNA constructs
Microinjections were performed in 4% Ficoll/0.3x MMR (Xenopus laevis) or 5% Ficoll/1x SS (Xenopus tropicalis). The maximum injection volume was 20 nl (Xenopus laevis) or 1 nl (Xenopus tropicalis) per embryo. The mMessage mMachine® sp6 Kit (Ambion) was used to synthesize in vitro capped mRNA. pCS2-super was generated by inserting an oligonucloetide fragment containing a polylinker sequence (EcoRI, PacI, SbfI, XmaI, XhoI, AscI, XbaI) into the EcoRI/XbaI sites of pCS2. pCS2-3xFLAG was generated by inserting a oligonucleotide fragment containing 3xFLAG followed by a stop codon into the XmaI/AscI sites of pCS2-super. To generate pCS2-apoc1, the Xenopus laevis apoc1 open reading frame (ORF) was obtained by RT-PCR from embryonic cDNA and subcloned into the PacI/ AscI sites of pCS2-super. pCS2-apoc1-3xFLAG was generated by PCR amplifying the apoc1 ORF without the stop codon and subcloning into the PacI/XmaI sites of pCS2-3xFLAG. pCS2-5'UTR-apoc1-3xFLAG was generated by subcloning a PCR fragment containing 42 base pairs of the apoc1 untranslated region directly upstream of the first methionine and the apoc1 ORF (without the stop codon) into the PacI/XmaI sites of pCS2-3xFLAG. Wnt3a was isolated from a Xenopus tropicalis full-length clone library (Source BioScience). In addition, GR-Ctnnb1 (b-catenin-GR), dominant negative bmpr1a (tBR), and chrd was used for making mRNA for injections.
Morpholino antisense oligos
Morpholino antisense oligos were synthesized by Gene Tools, LLC (USA). To design the Apoc1 translation blocking morpholino (tbMO), sequences of more than 50 EST clones were compared to identify a suitable conserved sequence in the five prime untranslated region. To design the apoc1 splice blocking MO (spMO), genomic DNA was amplified by PCR with the primer for exon 1 and 3, and several clones were sequenced, and the spMO was designed against the exon2-intron2 boundary. The sequences of the MOs are; tbMO: 5'-GGG CAC CTT CTT TAG AAA GCT CTG A-3', spMO: 5'-GTC AGG AAA AGA TAC TGT ACC TTG T-3', control MO: 5'-CCT CTT ACC TCA GTT ACA ATT TAT A-3'. The Gbx2.2 MO sequence has previously been reported (Li et al., 2009) . To test the efficiency of the tbMO, western blots were performed with a 5'UTR apoc1-flag construct described further below.
RNA isolation and RT-PCR assays
Total RNA extraction was performed using the TRIzol RNA isolation protocol (Life Technologies). The total RNA was treated with DNAseI (Roche), and cDNA was synthesized with the Maxima® First Strand cDNA Synthesis Kit for RT-qPCR (Thermo Scientific). The primers used were: apoc1-fwd CGC ACT GTC TGT GAT TCT GG, apoc1-rev CAG AGC TGG ACA CCT TTT CC, nodal3.2 (Darras et al., 1997) , odc1 (Heasman et al., 2000) , foxd3, pax3 and zic1 (sato et al., 2005) , otx2 (Mizuseki et al., 1998) , sox9 and six1 (Li et al., 2009) , snai1 and snai2 (LaBonne and Bronner-Fraser 1998).
Blastocoel cavity fluid collection and western blot
The blastocoel fluid was collected by inserting a thin needle connected to a PL1-100 Deluxe Pico Injector (Harvard Apparatus, Holliston, Massachusetts, USA) into the blastocoel cavity of stage 10 embryos. The blastocoel fluid from 10 embryos (approximately 0.2 ml / embryo) per condition was collected. As a control, total protein from whole embryos (5-10 embryos) was extracted by homogenizing the tissue on ice in extraction buffer [TrisHCl pH7.5, protease inhibitors (cOmplete, Mini Protease Inhibitor Cocktail Tablets, Roche)]. Homogenates were spun at 13,000 rpm for 2 minutes. The supernatant was prepared for Western blot by mixing with an equal volume of 2x reducing sample buffer and boiling. Approximately 1 embryo equivalent of protein extract was loaded on a 12% SDS-PAGE gel. The blastocoel fluid was diluted with extraction buffer, mixed with reducing sample buffer, and boiled. The entire blastocoel fluid sample was loaded on a 12% SDS-PAGE gel. The nitrocellulose membranes were blocked with 5% milk, incubated with anti-FLAG® M2 antibody (dilution 1:1125; F3165, Sigma Aldrich) overnight, and the signal was detected with SuperSignal® West Pico Chemiluminescent Substrate (Thermo Scientific). Finally, the membranes were stripped and stained with a a-tubulin antibody (dilution 1:10000; T5168, Sigma Aldrich) as a loading control.
Whole-mount in situ hybridization
The embryos were fixed in MEMFA for 2 hours at room temperature. Digoxigenin in situ hybridization was performed as described in (Harland 1991) with some modifications. NBT/BCIP was used as substrate for alkaline phosphatase. The Xenopus laevis apoc1 probe (pBKS-apoc1) was generated by ligating an EcoRI/XbaI fragment from pCS2-apoc1 into pBluescript KS.
Cycloheximide treatment
For blocking protein synthesis, embryos injected with 200pg of GRctnnb1were treated with 100 mg/ml cycloheximide 30 minutes prior to the dexamethasone treatment at st11.5. Embryos were then fixed with MEMFA at st13 (apc1, gbx2.2 and pax3) or st15 (snail2), and used for whole-mount in situ hybridization.
